From: Prescribing patterns of coronary artery aneurysm in Taiwan
Before index date | After index date | |||
---|---|---|---|---|
1 year | 3 month | 6 month | 1 year | |
N (%) | N (%) | N (%) | N (%) | |
Pediatric population (N = 586) | ||||
Aspirin | 182 (31.1) | 479 (81.7) | 482 (82.3) | 486 (82.9) |
Clopidogrel | 1 (0.2) | 4 (0.7) | 4 (0.7) | 4 (0.7) |
Dipyridamole | 43 (7.3) | 95 (16.2) | 97 (16.6) | 99 (16.9) |
Warfarin | 7 (1.2) | 25 (4.3) | 26 (4.4) | 27 (4.6) |
Heparin | 5 (0.9) | 31 (5.3) | 33 (5.6) | 34 (5.8) |
Adult population (N = 811) | ||||
Aspirin | 575 (70.9) | 667 (82.2) | 678 (83.6) | 689 (85.0) |
Clopidogrel | 256 (31.6) | 510 (62.9) | 514 (63.4) | 523 (64.5) |
Dipyridamole | 127 (15.7) | 81 (10.0) | 94 (11.6) | 108 (13.3) |
Ticlopidine | 32 (3.9) | 26 (3.2) | 31 (3.8) | 36 (4.4) |
Tirofiban | 22 (2.7) | 28 (3.5) | 28 (3.5) | 29 (3.6) |
Cilostazol | 20 (2.5) | 26 (3.2) | 29 (3.6) | 41 (5.1) |
Warfarin | 60 (7.4) | 126 (15.5) | 132 (16.3) | 141 (17.4) |
Heparin | 164 (20.2) | 551 (67.9) | 562 (69.3) | 577 (71.1) |
Enoxaparin | 60 (7.4) | 131 (16.2) | 140 (17.3) | 147 (18.1) |